Viking Therapeutics, Inc. (Nasdaq: VKTX) announced it has entered into a $12.5 million common stock purchase agreement with Aspire Capital ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE